Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents | Zendy

Juan C. Salazar | Zendy; Pedro Cahn | Zendy; Ram Yogev | Zendy; Marinella Della Negra | Zendy; Guido Castelli Gattinara | Zendy; Clàudia Fortuny | Zendy; Patrica M Flynn | Zendy; Carlo Giaquinto | Zendy; Ping Ruan | Zendy; Mary E. Smith | Zendy; Jaromir Mikl | Zendy; Ante Jelaska | Zendy

Open Access

Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents

Author(s) -

Juan C. Salazar,

Pedro Cahn,

Ram Yogev,

Marinella Della Negra,

Guido Castelli Gattinara,

Clàudia Fortuny,

Patrica M Flynn,

Carlo Giaquinto,

Ping Ruan,

Mary E. Smith,

Jaromir Mikl,

Ante Jelaska

Publication year - 2008

Publication title -

aids

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.195

H-Index - 216

eISSN - 1473-5571

pISSN - 0269-9370

DOI - 10.1097/qad.0b013e32830c481b

Subject(s) - tolerability , medicine , ritonavir , regimen , adverse effect , viral load , vomiting , gastroenterology , randomized controlled trial , protease inhibitor (pharmacology) , diarrhea , pharmacology , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy

To evaluate the efficacy, safety and tolerability of ritonavir-boosted tipranavir (TPV/r) in HIV-1-infected pediatric patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog